HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Factors that influence the severity of recurrent hepatitis C virus following liver transplantation.

Abstract
Poor outcomes following OLT for HCV disease have been associated with several host, viral, and non-host/non-viral factors. As is evident from the literature, there is confounding data in favor of and against these factors in the pathogenesis of severe recurrent HCV. Nevertheless, from a viral perspective, the patient most likely to achieve a good outcome following OLT is someone with low-level (< or = 10(9) copies/mL) HCV RNA viremia both pre- and post-OLT and a genotype other than lb. In terms of host factors, the patients with best outcomes are: whites, men, less than 49 years of age, receiving a donor liver less than 40 years of age, not coinfected with CMV, and have low HAI or histologic activity indices during the early stage of follow-up. Host recipient immune homology may or may not be a major factor in outcomes. A non-host, non-viral factor favoring less severe recurrence of HCV is a shorter warm ischemia time. Finally, features that may influence outcomes over which there is no control include: recipient age, recipient gender, and donor age (in the case of cadaveric donors). Unfortunately, the best-case scenario is uncommon.
AuthorsSteven B Porter, K Rajender Reddy
JournalClinics in liver disease (Clin Liver Dis) Vol. 7 Issue 3 Pg. 603-14 (Aug 2003) ISSN: 1089-3261 [Print] United States
PMID14509529 (Publication Type: Journal Article, Review)
Topics
  • Age Factors
  • Female
  • Genotype
  • Graft Rejection (virology)
  • Hepacivirus (growth & development)
  • Hepatitis C, Chronic (pathology, surgery, virology)
  • Humans
  • Immunosuppression Therapy (methods)
  • Liver Transplantation
  • Male
  • Organ Preservation (methods)
  • Recurrence
  • Sex Factors
  • Viremia (pathology, virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: